Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health

PJ Mogayzel Jr, ET Naureckas… - American journal of …, 2013 - atsjournals.org
Rationale: Cystic fibrosis (CF) is an autosomal recessive disease characterized by abnormal
airways secretions, chronic endobronchial infection, and progressive airway obstruction …

Stenotrophomonas maltophilia: an emerging global opportunistic pathogen

JS Brooke - Clinical microbiology reviews, 2012 - Am Soc Microbiol
Stenotrophomonas maltophilia is an emerging multidrug-resistant global opportunistic
pathogen. The increasing incidence of nosocomial and community-acquired S. maltophilia …

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel …

N Mayer-Hamblett, F Ratjen, R Russell… - The Lancet …, 2023 - thelancet.com
Background Reducing treatment burden is a priority for people with cystic fibrosis, whose
health has benefited from using new modulators that substantially increase CFTR protein …

Pathophysiology and management of pulmonary infections in cystic fibrosis

RL Gibson, JL Burns, BW Ramsey - American journal of respiratory …, 2003 - atsjournals.org
This comprehensive State of the Art review summarizes the current published knowledge
base regarding the pathophysiology and microbiology of pulmonary disease in cystic …

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis

MR Elkins, M Robinson, BR Rose… - … England Journal of …, 2006 - Mass Medical Soc
Background Inhaled hypertonic saline acutely increases mucociliary clearance and, in short-
term trials, improves lung function in people with cystic fibrosis. We tested the safety and …

Cystic fibrosis adult care: consensus conference report

JR Yankaskas, BC Marshall, B Sufian, RH Simon… - Chest, 2004 - journal.chestnet.org
Abbreviations: ADA Americans with Disabilities Act; BMD bone mineral density; BMI body
mass index; CBAVD congenital bilateral absence of the vas deferens; CF cystic fibrosis; CFF …

Managing cough as a defense mechanism and as a symptom: a consensus panel report of the American College of Chest Physicians

RS Irwin, LP Boulet, MM Cloutier, R Fuller, PM Gold… - Chest, 1998 - journal.chestnet.org
1. Cough can (a) be an important defense mechanism to help clear excessive secretions
and foreign material from airways;(b) be an important factor in the spread of infection;(c) …

Mucus clearance and lung function in cystic fibrosis with hypertonic saline

SH Donaldson, WD Bennett, KL Zeman… - … England Journal of …, 2006 - Mass Medical Soc
Background Abnormal homeostasis of the volume of airway surface liquid in patients with
cystic fibrosis is thought to produce defects in mucus clearance and airway defense …

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health

PA Flume, BP O'Sullivan, KA Robinson… - American journal of …, 2007 - atsjournals.org
Rationale: Cystic fibrosis is a recessive genetic disease characterized by dehydration of the
airway surface liquid and impaired mucociliary clearance. As a result, individuals with the …

Airway surface dehydration in cystic fibrosis: pathogenesis and therapy

RC Boucher - Annu. Rev. Med., 2007 - annualreviews.org
Cystic fibrosis (CF) lung disease reflects the failure of airways defense against chronic
bacterial infection. Studies of CF cultures, transgenic mice, and CF patients suggest that the …